AzTrials
AzTrials

Obsessive-Compulsive DisorderNCT05855902

Art Therapy in an Intensive OCD Program

An observational study of Obsessive-Compulsive Disorder, run by Sunnybrook Health Sciences Centre at 1 site in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The Thompson Centre Intensive Treatment program for individuals with severe Obsessive-Compulsive Disorder was launched in 2017. The program is focused on the principles and use of Exposure and Response Prevention Therapy (ERP) and Cognitive Behavioural Therapy (CBT) in its work with clients, however it also integrates… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Obsessive-Compulsive Disorder
What is being tested?
group art therapy
How many people
100 participants
Where
1 siteCanada
Study dates
23 Mar 2023to 30 Mar 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Adults diagnosed with Obsessive-Compulsive Disorder, enrolled in the Thompson Centre Intensive Treatment Program.

Who may be able to join

  • Must have been accepted into and begun the Intensive Treatment Program for OCD at the Thompson Centre, whether participating as a residential or day treatment participant.

Who cannot join

  • No other patients/clients in the hospital or its outpatient programs will be considered for this study. No-one who is not a patient or client in this program can participate

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Sunnybrook Health Sciences Centre

    Toronto, Ontario, M4N 3M5

Other trials in Canada

About this study

Official title: Art Therapy in an Intensive OCD Program: Client Perception of Value

The Thompson Centre Intensive Treatment program for individuals with severe Obsessive-Compulsive Disorder was launched in 2017.

The program is focused on the principles and use of Exposure and Response Prevention Therapy (ERP) and Cognitive Behavioural Therapy (CBT) in its work with clients, however it also integrates other treatment approaches in its structure, including Dialectical Behavior Therapy, Mindfulness, Acceptance and Commitment Therapy, and Art Therapy. Clients are expected to participate in Art Therapy group in the same way they are expected to participate in all other groups in the program schedule.

Read more

Though clients comment informally on the benefits of Art Therapy as experienced in the program, study is needed to better understand and appreciate the role Art Therapy can play in helping clients with OCD to manage and where possible, ameliorate, the burden of their symptoms.

Although Art Therapy has been researched to some degree, in particular its role in alleviating distress associated with various health and mental health conditions, to date there has been no systematic investigation addressing or supporting patients'/clients' perception of the value of Art Therapy by people who live with Obsessive Compulsive Disorder (OCD).

In this study, the investigators are proposing to use information from client surveys regarding their experiences in an Art Therapy group within an intensive OCD treatment program, regarding their experience and opinions about the benefits of Art Therapy within a structured, intensive program for individuals who live with severe OCD. Therefore, this proposed study would be an entirely new contribution both to the fields of Art Therapy and OCD.

The hypothesis of the study is that individuals with severe Obsessive-Compulsive Disorder participating in an intensive CBT/ERP treatment program will report benefits specific to their experience in Art Therapy sessions within the program.

Read the detailed description

Objective:

To evaluate patients'/clients' perceptions of the value of art therapy as a treatment component in an intensive CBT/ERP program for individuals with severe OCD.

To this end, survey responses will be collected from clients in the program and analyzed to identify key benefits of including Art Therapy as a component of their treatment experience.

Study logistics:

All clients in the Intensive Treatment Program are expected to attend all groups, Art Therapy included.

Clients will be informed by staff at the beginning of the program, and by the PI in the first Art Therapy group attended, about the study and will be requested to fill out questionnaires they will receive.

After the first Art Therapy group they will be asked to fill out and submit the first questionnaire. After their last group in the program they will be asked to fill out a final questionnaire.

Those who have already completed the program have submitted completed questionnaires and the data from this will be analyzed retrospectively. The data has been de-identified.

Those who begin the program in June will also be offered a beginning and closing questionnaire, and written consent will be sought to use this data for the prospective part of the study.

Method:

Clients who participate in weekly Art Therapy group will be given one questionnaire to complete after their first art therapy group, and one to complete after their tenth group/tenth week in the program. The questionnaire will be a revised version of the questionnaire that has been given to the clients for the retrospective study data gathering.

Data Analysis:

Clients in an intensive OCD residential/day treatment program - men and women age 18 and up are given two electronic surveys, one at the beginning of their 10-week treatment experience, asking questions pertaining to their experience of Art Therapy after their first session, and at the end of their time in the program, asking them to reflect on their overall experience of Art Therapy in the program.(surveys attached). A descriptive statistical analysis will be used to analyze study data.

Procedures for confidentiality/anonymity:

Participant information will be stored on REDCAP, a confidential and encrypted platform for data collection and storage. All participants will have identifying numbers that are de-linked from their names. This date is password-protected: only the research team will have access to this information.

Being tested
group art therapy
Medical subject headings
Obsessive-Compulsive Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • group art therapyBehavioural

    Art therapy will be offered in a weekly 1.5 hour group. Clients are provided a prompt and then asked to express their feelings using art, such as drawing/painting/etc.

Study groups in NCT05855902
Study groupRoleWhat they receive
Adults with OCDAdults with OCD in an intensive treatment program will participate in weekly Art Therapy sessions during their enrollment in the program. Each group is 1.5 hours long. Each participant will be asked to fill out one survey after their first Art Therapy group, and one at the end of the time in the program. Both surveys pertain to their perceptions of the value of Art Therapy within the program.
Receives: Behavioral: group art therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Art Therapy Questionnaire

    Acceptability of art therapy as rated by scores on the Art Therapy Questionnaire

    Measured: October 2020 - November 2023

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 May 2023
  2. Study start23 Mar 2023
  3. Primary completion30 Mar 2025 (estimated)
  4. Study completion30 Mar 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05855902
Sponsor's protocol ID
5341
Status last verified
May 2023
First submitted
27 Mar 2023
Last updated
12 May 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Obsessive-Compulsive Disorder, run by Sunnybrook Health Sciences Centre at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Art Therapy Questionnaire (time frame: October 2020 - November 2023). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 May 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in